Nikolaos Grigoriadis
Neurology — AHEPA University Hospital, Greece
Nikolaos Grigoriadis
LeadR Profile
Neurology
Subspecialties: Immunology - Biochemistry - Psychiatry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 374
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Autonomic Dysfunction After Guillain-Barré Syndrome: Evidence from Comprehensive Autonomic Testing. research design, autonomic nervous system, primary dysautonomias, guillain-barre syndrome, nervous system | J Clin Med | 2026 | 0 |
| Preserved α2 oscillations underpin reserve-related resilience of semantic verbal fluency in multiple sclerosis. sclerosis, multiple sclerosis, semantics, cognitive reserve, mediation analysis, negotiating | Front Neurosci | 2026 | 0 |
| Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis. sclerosis, multiple sclerosis, incidence, therapeutics, wounds and injuries, neurology, multiple sclerosis, relapsing-remitting | Brain | 2026 | 0 |
| Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis. sclerosis, multiple sclerosis, aging, brain, immunosenescence, immune system diseases, therapeutics | Front Immunol | 2026 | 0 |
| Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting. sclerosis, multiple sclerosis, disease management, therapeutics | Brain Sci | 2026 | 0 |
Clinical Studies 14
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 3
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A study to investigate long term safety and tolerability of tolebrutinib in participants with multiple sclerosis 2023-503631-18-01 — sclerosis, multiple sclerosis, safety, nervous system, nervous system diseases, primary progressive multiple sclerosis, secondary progressive multiple sclerosis | Phase 3 | Active not recruiting | 2024 |
| Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis followed by long term treatment with remibrutinib 2023-509372-41-00 — sclerosis, multiple sclerosis, safety, therapeutics | Phase 3 | Active not recruiting | 2022 |
| A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis 2025-521546-23-00 — sclerosis, multiple sclerosis, safety, secondary progressive multiple sclerosis | Phase 3 | Recruiting | 2026 |
| Administration of Fingolimod in Greek Patients With Multiple Sclerosis NCT06949956 — sclerosis, multiple sclerosis, safety, multiple sclerosis, relapsing-remitting | N/A | Not yet recruiting | 2025 |
LeadR Networks
Main global connection map